From: Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-study
Chronic disease | ICD-10-codes | Hx (D) | hx1(D) [%] | hx2(D) [%] |
---|---|---|---|---|
Chronic infectious and parasitic diseases | ∑ | 6 | 0.1 | 0.5 |
Tuberculosis | A15.- until A19.- and B90.9 | 3 | 0.1 | 0.3 |
Hepatitis | B18.- and K73.- | 3 | 0.1 | 0.3 |
Chronic diseases of the blood | ∑ | 21 | 0.4 | 1.8 |
Anemia | D50.- until D64.- | 7 | 0.1 | 0.6 |
Other chronic diseases of the blood | D65.- until D69.- and D73.0 | 14 | 0.3 | 1.2 |
Metabolic disorders | ∑ | 167 | 3.1 | 14.6 |
Hypothyreoidism | E03.- and E89.0 | 76 | 1.4 | 6.7 |
Hyperthyreoidism | E05.- | 19 | 0.4 | 1.7 |
Other metabolic disorders | E00.- until E02.- and E04.- and E06.2 until E07.- and E89.1 until E89.9 | 27 | 0.5 | 2.4 |
Diabetes mellitus | E10.- until E14.- and O24.0 until O24.3 | 11 | 0.2 | 1 |
Other endocrine diseases | E20.- until E29.- and E31.- until E35.- | 6 | 0.1 | 0.5 |
Alimentary deficiencies | E40.- until E46.- and E50.- until E64.- | 4 | 0.1 | 0.4 |
Supernutrition | E65.- until E68.- | 9 | 0.2 | 0.8 |
Other metabolic disorders | E70.- until E85.- and E88.- and E90.- | 15 | 0.3 | 1.3 |
Mental and behavioural disorders | F00.- until F99.- | 20 | 0.4 | 1.8 |
Chronic diseases of the nervous system | ∑ | 116 | 2.2 | 10,.2 |
Multiple sclerosis | G35.- | 1 | 0 | 0.1 |
Epilepsy | G40.- | 30 | 0.6 | 2.6 |
Migraine | G43.- | 80 | 1.5 | 7 |
Diseases of the cerebral nerves | G50.- until G53.- | 1 | 0 | 0.1 |
Diseases of the PNS | G54.- until G64.- | 2 | 0 | 0.2 |
Myopathies and paresis | G70.- until G73.- and G80.- until G83.- and R25.2 | 2 | 0 | 0.2 |
Chronic diseases of the eye | ∑ | 33 | 0.6 | 2.9 |
Chronic disease of the iris and the ciliary body | H20.1 until H22.- | 2 | 0 | 0.2 |
Chronic disease of the retina | H33.- until H36.- | 4 | 0.1 | 0.4 |
Glaucoma | H40.- until H42.- | 7 | 0.1 | 0.6 |
Disorders of optic nerve and visual pathways | H46.- until H48.- | 2 | 0 | 0.2 |
Disorders of accommodation and refraction and other visual disturbances | H49.- until H54.- | 18 | 0.3 | 1.6 |
Chronic diseases of the ear | ∑ | 18 | 0.3 | 1.6 |
Chronic diseases of middle ear and mastoid | H65.2 until H65.9 and H66.1 until H69.x and H73.1 until H73.9 | 5 | 0.1 | 0.4 |
Chronic diseases of inner ear | H80.- until H83.- | 1 | 0 | 0.1 |
Other disorders of ear | H90.- until H95.- | 12 | 0.2 | 1.1 |
Chronic diseases of the circulatory system | ∑ | 113 | 2.1 | 9.9 |
Hypotension | I95.- and R55.- | 15 | 0.3 | 1.3 |
Hypertension | I10.- until I15.- | 58 | 1.1 | 5.1 |
Chronic heart diseases | I31.- until I32.- and I34.- until I39.- and I42.- until I43.- and I50.- until I52.- | 4 | 0.1 | 0.4 |
Cardiac conduction disorders | I44.- until I49.- and R00.- | 16 | 0.3 | 1.4 |
Cerebrovascular diseases | I60.- until I69.- | 2 | 0 | 0.2 |
Other vascular diseases | I26.- and I70.- until I73.- and I77.- until I80.- and I83.- until I89.- and I99.- | 18 | 0.3 | 1.6 |
Chronic upper respiratory diseases | J31.- until J35.- and J37.- until J38.- | 7 | 0.1 | 0.6 |
Chronic lower respiratory diseases | ∑ | 159 | 3 | 13.9 |
COPD | J44.- | 1 | 0 | 0.1 |
Asthma bronchiale | J45.- | 144 | 2.7 | 12.6 |
Other chronic lower respiratory diseases | J40.- until J43.- and J47.- and J95.3 until J95.9 and J96.1 until J96.9 | 14 | 0.3 | 1.2 |
Chronic diseases of the upper digestive system | ∑ | 9 | 0.2 | 0.8 |
GERD | K21.- | 5 | 0.1 | 0.4 |
Other chronic diseases of the upper digestive system | K22.- and K29.3 until K29.7 and K31.1 until K31.5 and R12.- and Z90.3 | 4 | 0.1 | 0.4 |
Chronic diseases of the lower digestive system | ∑ | 12 | 0.2 | 1.1 |
Chronic inflammatory bowel diseases | K50.- until K52.- | 3 | 0.1 | 0.3 |
Other chronic diseases of the lower digestive system | K55.1 and K58.- and K59.- until K63.- and K92.8 until K92.9 and R15.- | 3 | 0.1 | 0.3 |
Disorders of malabsorption | K90.- until K91.- | 6 | 0.1 | 0.5 |
Chronic diseases of liver, gallbladder and pancreas | K70.-, K74.-, K76.-, K80.-, K81.1 until K83.-, K86.- | 3 | 0.1 | 0.3 |
Chronic diseases of the skin | ∑ | 118 | 2.2 | 10.3 |
Dermatitis | L20.-, L21.-, L24.-, L25.-, L26.-, L27.2 until L27.9, L30.- | 105 | 2 | 9.2 |
Other chronic diseases of the skin | L55.- until L59.-, L70.- until L75.-, L80.- | 13 | 0.2 | 1.1 |
Immune mediated diseases | ∑ | 37 | 0.7 | 3.2 |
Psoriasis | L40.- | 20 | 0.4 | 1.8 |
Urticaria | L50.- | 4 | 0.1 | 0.4 |
Lupus erythematodes | L93.-, M32.- | 1 | 0 | 0.1 |
Arthropathies | M05.- until M19.-, M79.0- | 7 | 0.1 | 0.6 |
Diseases of the connective tissue | M30.-, M31.-, M33.- until M36.-, R60.- | 4 | 0.1 | 0.4 |
Other immune mediated diseases | K75.4 | 1 | 0 | 0.1 |
Chronic diseases of the musculoskeletal system | ∑ | 39 | 0.7 | 3.4 |
Dorsopathies | M40.- until M54.- | 36 | 0.7 | 3.2 |
Chondropathies | M91.- until M94.- | 1 | 0 | 0.1 |
Other chronic diseases of the musculoskeletal system | M95.- until M99.- | 2 | 0 | 0.2 |
Chronic diseases of the urinary tract collection system | ∑ | 43 | 0.8 | 3.8 |
Glomerular diseases | N01.- until N05.- | 5 | 0.1 | 0.4 |
Renal tubulo-interstitial diseases | N11.- until N16.- | 24 | 0.5 | 2.1 |
Urolithiasis | N20.- until N23.- | 7 | 0.1 | 0.6 |
Other chronic diseases of the urinary tract | N18.-, N26.-, N28.-, N29.-, N30.1 until N33.-, N39.- | 7 | 0.1 | 0.6 |
Chronic diseases of the female genital tract | ∑ | 7 | 0.1 | 0.6 |
Noninflammatory disorders | N80.- until N90.- | 5 | 0.1 | 0.4 |
Chronic inflammatory disorders | N70.1; N71.1; N72.-; N73.1; N73.4; N76.1; N76.3 | 1 | 0 | 0.1 |
Other chronic diseases of the femal genital tract | N91.- until N94.- | 1 | 0 | 0.1 |
Congenital malformations, deformations and chromosomal | Q00.- until Q99.-, P00.-, P96.- | 18 | 0.3 | 1.6 |
abnormalities and conditions of the fetus originating in the perinatal period | 0 | |||
Chronic pangs | G09.-, G44.-, R10.1 until R10.4, R51.-, R52.1 until R52.9 | 11 | 0.2 | 1 |
Allergies | ∑ | 601 | 11.3 | 52.7 |
Systemic | J30.- and T63.4 and T78.1 and T78.4 and T88.7 and Z88.- | 474 | 8.9 | 41.5 |
Dermatic | L23.- and L56.4 | 127 | 2.4 | 11.1 |